gentamicin has been researched along with beta-lactams in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (22.22) | 18.7374 |
1990's | 8 (11.11) | 18.2507 |
2000's | 12 (16.67) | 29.6817 |
2010's | 30 (41.67) | 24.3611 |
2020's | 6 (8.33) | 2.80 |
Authors | Studies |
---|---|
Sykes, RB | 1 |
Panwalker, AP; Trager, GM; White, GW; Zimelis, VM | 1 |
Kojo, H; Mine, Y; Nishida, M; Nonoyama, S | 1 |
Ullmann, U | 1 |
Kraus, LL; Lewis, RP; Meyer, RD | 1 |
Bingen, E; Courvalin, P; Duval, J; Lambert-Zechovski, N; Leclercq, R; Su, QH | 1 |
Feldman, S; Ravis, WR; Van, R; Walterspiel, JN | 1 |
Chin, NX; Neu, HC | 1 |
Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
Brückner, O; Hahn, H; Marre, R; Trautmann, M | 1 |
Chan, LY; Wallace, SM | 1 |
Ackerman, VP; Fernandes, CJ; Stevens, DA | 1 |
Spitzy, KH | 1 |
Cherubin, C; Eng, RH; Smith, SM | 1 |
Cowlishaw, A; Eley, A; Elliott, TS | 1 |
Glew, RH; Pavuk, RA | 1 |
Marks, MI; Scribner, RK; Tarpay, MM; Weber, AH; Welch, DF | 1 |
Giron, KP; Gross, ME; Mason, EO; Musher, DM; Septimus, JD | 1 |
Farinati, A; Jugo, M; Villar, H | 1 |
Godard, C; Hannecart-Pokorni, E; Hubrechts, JM; Maes, P; Nulens, E; Nyssen, HJ; Vanhoof, R; Wildemauwe, C | 1 |
Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Tanaka, S | 2 |
Aubert, G; Carricajo, A; Fonsale, N; Vautrin, AC | 1 |
Ida, T; Inoue, M; Irinoda, K; Kurazono, M; Nonoyama, M; Okamoto, R | 1 |
Carryn, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F | 1 |
Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC | 1 |
Bruun, NE; Mellerup, MT; Nielsen, JD | 1 |
Cheng, NC; Hsueh, PR; Huang, WK; Liu, CY; Liu, YC; Shyr, JM; Teng, LJ | 1 |
Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
Biedenbach, DJ; Huynh, HK; Jones, RN | 1 |
Cubells, CL; García-García, JJ; Giralt, AG; Magín, EC; Sert, SZ | 1 |
Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
Ablij, HC; Assendelft, WJ; Blom, JW; Delfos, NM; Elzevier, HW; Koster, T; Kuijper, EJ; Leyten, EM; Pander, J; Spelt, IC; van Dissel, JT; van Nieuwkoop, C; van't Wout, JW; Wattel-Louis, GH | 1 |
Acred, P; Ryan, DM; Sowa, MA; Watts, CM | 1 |
Brown, NM; Carmichael, AJ; Cooke, FJ; Ganner, M; Gkrania-Klotsas, E; Howard, JC; Kearns, AM; Stone, M | 1 |
Lee, HJ; Lee, KM; Suh, JT; Yang, HY | 1 |
De Souza, C; Gbeassor, M; Ilboudo, DP; Karou, SD; Nadembega, MC; Ouermi, D; Pietra, V; Pignatelli, S; Simpore, J; Zeba, B | 1 |
Apuzzio, JJ; Brown, KR; Williams, SF | 1 |
Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
Gruszczyńska, B; Kaznowski, A; Mokracka, J | 1 |
Casini, B; Ferranti, S; Flammini, S; Giani, T; Leonildi, A; Lewis, R; Menichetti, F; Rossolini, GM; Tagliaferri, E; Tascini, C | 1 |
Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
Bayraktar, B; Celebi, S; Dalgic, N; Dokucu, AI; Kafadar, I; Kara, O; Karadag, CA; Pelit, S; Sancar, M | 1 |
Fabry, WH; Kock, HJ; Vahlensieck, W | 1 |
Almaghrabi, R; Chen, L; Clancy, CJ; Doi, Y; Hao, B; Iovine, NM; Kreiswirth, B; Nguyen, MH; Press, EG; Shields, RK; Townsend, BM; Wagener, MM | 1 |
Belova, VV; Bulovskaia, LN; Erbasskaia, AV; Govorova, LV; Ivanova, VV | 1 |
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
Coates, A; Hu, Y; Kearns, A; Liu, A; McTavish, SM; Moigboi, C; Vaiciunaite, B; Vaudrey, J | 1 |
Berkley, JA; Obiero, CW; Seale, AC | 1 |
Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A | 1 |
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ | 1 |
Cavaco-Silva, P; Matias, CS; Melo-Cristino, J; Mendes, JJ; Mottola, C; Oliveira, M; Tavares, L | 1 |
Al-Hasan, MN; Ereshefsky, BJ; Gokun, Y; Martin, CA | 1 |
Ariano, RE; Calic, D; Lawson, C; Lipman, J; Roberts, JA; Zelenitsky, SA; Zhanel, GG | 1 |
Abdissa, A; Kannan, H; Mengist, A | 1 |
Endimiani, A; Furrer, H; Hirzberger, L; Hirzel, C | 1 |
Dinic, M; Kocic, B; Mitic, R; Mladenovic-Antic, S; Petrovic, J; Randjelovic, G; Velickovic-Radovanovic, R | 1 |
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
Ebara, Y; Iwata, S; Moritoki, N; Morozumi, M; Murata, M; Sato, M; Takata, M; Toyofuku, M; Ubukata, K | 1 |
Görür, K; İsmi, O; Özcan, C; Vayisoğlu, Y; Yeşilova, M | 1 |
Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL | 1 |
Azimi, L; Rastegar Lari, A | 1 |
Castegren, M; Furebring, M; Lipcsey, M; Sjölin, J | 1 |
Chen, CJ; Chuang, YY; Huang, YC; Ko, WC; Lauderdale, TY; Lee, CY; Lu, CT; Lu, MC; Wu, TS; Yang, CC | 1 |
Hao, W; He, Y; Mafiz, A; Perera, LN; Sun, S; Xiao, S; Zhang, W; Zhang, Y; Zhou, K | 1 |
Agarwal, R; Bielicki, JA; Cromwell, DA; Heath, PT; Sharland, M; Turner, P; Walker, AS | 1 |
Fredlund, H; Källman, J; Liljedahl Prytz, K; Magnuson, A; Prag, M; Sundqvist, M | 1 |
Everson, N; Freeman, L; McDaniel, L; Milkovits, A | 1 |
Araújo, NJS; Coutinho, HDM; da Silva, ARP; de Freitas, TS; de Sousa, EO; de Vasconcelos, JEL; do Socorro Costa, M; Filho, JMB; Maia, FPA; Pereira Junior, FN; Pinheiro, JCA; Tavares, JF | 1 |
Das, AK; Dudeja, M; Kohli, S; Ray, P | 1 |
Ahmed, A; Anwaar, F; Ghumman, NZ; Ijaz, M; Javed, MU; Muzammil, I; Rasheed, H; Raza, A | 1 |
3 review(s) available for gentamicin and beta-lactams
Article | Year |
---|---|
Resistance of Pseudomonas aeruginosa to antimicrobial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cell Membrane; Cell Membrane Permeability; Cephalosporins; Edetic Acid; Gentamicins; Mutation; Penicillin Resistance; Penicillinase; Penicillins; Polymyxins; Preservatives, Pharmaceutical; Pseudomonas aeruginosa; Tetracyclines | 1975 |
Empiric treatment of neonatal sepsis in developing countries.
Topics: Anti-Bacterial Agents; beta-Lactams; Developing Countries; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Sepsis | 2015 |
Evaluation of the Coverage of 3 Antibiotic Regimens for Neonatal Sepsis in the Hospital Setting Across Asian Countries.
Topics: Anti-Bacterial Agents; Asia; Bacteria; beta-Lactams; Clinical Decision-Making; Decision Trees; Drug Resistance, Bacterial; Drug Therapy, Combination; Gentamicins; Humans; Incidence; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis | 2020 |
2 trial(s) available for gentamicin and beta-lactams
Article | Year |
---|---|
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Double-Blind Method; Female; Fever; Gentamicins; Humans; Male; Urinary Tract Infections | 2009 |
Ertapenem versus standard triple antibiotic therapy for the treatment of perforated appendicitis in pediatric patients: a prospective randomized trial.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Child; Child, Preschool; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gentamicins; Humans; Infant; Intestines; Male; Prospective Studies; Surgical Wound Infection | 2014 |
67 other study(ies) available for gentamicin and beta-lactams
Article | Year |
---|---|
LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Drug Synergism; Gentamicins; Microbial Sensitivity Tests | 1979 |
Nocardicin A, a new monocyclic beta-lactam antibiotic III. In vitro evaluation.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Blood Bactericidal Activity; Blood Proteins; Carbenicillin; Dogs; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Neisseria; Neutrophils; Nocardia; Protein Binding; Proteus; Pseudomonas aeruginosa; Rabbits | 1977 |
[In vitro experiments on the working of combinations of gentamicin and beta-lactam antibiotics against Pseudonomas aeruginosa (author's transl)].
Topics: Bacteriological Techniques; beta-Lactams; Carbenicillin; Drug Combinations; Gentamicins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 1975 |
Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins | 1976 |
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Glycopeptides; Peptides; Streptococcus; Time Factors | 1991 |
Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cilastatin; Drug Interactions; Fluorescence Polarization Immunoassay; Gentamicins; Heparin; Humans | 1991 |
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
Comparative efficacy of different beta-lactam antibiotics and gentamicin in Klebsiella pneumoniae septicaemia in neutropenic mice.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Neutropenia; Sepsis | 1986 |
In vitro interaction of aminoglycosides with beta-lactam penicillins.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Interactions; Gentamicins; Humans; In Vitro Techniques; Kidney; Kinetics; Models, Theoretical; Statistics as Topic; Tobramycin | 1985 |
Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1985 |
[Appearance of exanthema during hing-dosage therapy with beta-lacta antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cephalosporins; Drug Eruptions; Drug Therapy, Combination; Exanthema; Gentamicins; Humans; Oxacillin; Penicillin G; Penicillins | 1974 |
Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.
Topics: Amino Acids; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Gentamicins; Kinetics; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Pseudomonas aeruginosa | 1984 |
Stability of gentamicin in combination with selected new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Combinations; Drug Stability; Gentamicins; Humans | 1984 |
Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Chemistry, Pharmaceutical; Drug Combinations; Drug Stability; Gentamicins; Temperature; Tobramycin | 1983 |
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1982 |
Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1995 |
[Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus agalactiae | 1994 |
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
Topics: Amikacin; Anti-Bacterial Agents; Belgium; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; Humans; Pseudomonas aeruginosa; Serotyping | 1993 |
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits | 1994 |
[Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 3. The results against Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1996 |
[Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 2. The results against enterobacteriaceae].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1996 |
In vitro activity of beta-lactams against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 2000 |
Antagonism between aminoglycosides and beta-lactams in a methicillin-resistant Staphylococcus aureus isolate involves induction of an aminoglycoside-modifying enzyme.
Topics: Acetyltransferases; Anti-Bacterial Agents; beta-Lactams; Conjugation, Genetic; Drug Antagonism; Drug Resistance, Bacterial; Gentamicins; Humans; Kanamycin Kinase; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Netilmicin; Sequence Analysis, DNA; Staphylococcus aureus | 2002 |
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; beta-Lactams; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Quinolines | 2002 |
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.
Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2005 |
[Increased bleeding tendency induced by beta-lactam antibiotics].
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Gentamicins; Hemorrhage; Humans; Male; Middle Aged; Penicillins; Shock, Septic | 2005 |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gentamicins; Hospitals, University; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline | 2005 |
Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 2005 |
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside.
Topics: Aminoglycosides; beta-Lactam Resistance; beta-Lactams; Carbapenems; Doripenem; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2006 |
Efficacy of short-term intravenous antibiotic in neonates with urinary tract infection.
Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Follow-Up Studies; Gentamicins; Humans; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Assessment; Treatment Outcome; Urinalysis; Urinary Tract Infections | 2007 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporins; Colony Count, Microbial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests | 1981 |
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Users; Erythromycin; Fusidic Acid; Gentamicins; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Phenotype; Staphylococcal Infections; United Kingdom; Young Adult | 2010 |
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests | 2009 |
[Evolution of antibiotic-resistance Staphylococcus aureus in Saint Camille Medical Centre in Ouagadougou].
Topics: Academic Medical Centers; Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Burkina Faso; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Oleandomycin; Pristinamycin; Retrospective Studies; Sputum; Staphylococcal Infections; Staphylococcus aureus; Suppuration; Urine | 2010 |
Ertapenem compared to combination drug therapy for the treatment of postpartum endometritis after cesarean delivery.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cesarean Section; Clindamycin; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Endometritis; Ertapenem; Female; Gentamicins; Humans; Infant, Newborn; Postnatal Care; Pregnancy; Puerperal Infection; Retrospective Studies; Young Adult | 2012 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Proteus mirabilis; Proteus vulgaris; Sequence Analysis, DNA; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Genes, Bacterial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability; Rifampin | 2013 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Activity of the antiseptic polyhexanide against gram-negative bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; beta-Lactams; Biguanides; Ciprofloxacin; Drug Combinations; Escherichia coli; Gentamicins; Haemophilus influenzae; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability; Moraxella catarrhalis; Pseudomonas aeruginosa | 2014 |
Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enzyme Assays; Gene Expression; Gentamicins; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin | 2014 |
[Efficiency of antibiotics in children with acute respiratory infection complicated by pneumonia dependent on the acetylation type in the Far North regions].
Topics: Acetylation; Acetyltransferases; Anti-Bacterial Agents; beta-Lactams; Biotransformation; Child; Child, Preschool; Cold Climate; Ethnicity; Female; Gentamicins; Humans; Male; Pneumonia, Bacterial; Polymorphism, Genetic; Respiratory Tract Infections; Russia; Treatment Outcome | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Amoxicillin; Animals; beta-Lactams; Female; Gentamicins; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Penicillins; Peptides; Staphylococcal Infections; Staphylococcus aureus | 2015 |
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Daptomycin; DNA Mutational Analysis; DNA, Bacterial; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enterococcus faecium; Ertapenem; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Vancomycin Resistance | 2015 |
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin | 2016 |
Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Biofilms; Ceftaroline; Cephalosporins; Diabetic Foot; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Tobramycin; Treatment Outcome | 2017 |
Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.
Topics: Abdomen; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Cefoxitin; Clindamycin; Computer Simulation; Drug Dosage Calculations; Ertapenem; Female; Gentamicins; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Monte Carlo Method; Surgical Wound Infection | 2016 |
Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Carrier State; Cross-Sectional Studies; Ethiopia; Female; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Pregnancy; Prevalence; Rectum; Streptococcal Infections; Streptococcus agalactiae; Vagina | 2016 |
Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae.
Topics: Aerococcus; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Colony Count, Microbial; Daptomycin; Drug Synergism; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Time Factors | 2016 |
Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Gentamicins; Hospitals; Humans; Imipenem; Meropenem; Pseudomonas aeruginosa; Serbia; Thienamycins | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus agalactiae | 2017 |
Difficult Cases of Odontogenic Deep Neck Infections: A Report of Three Patients.
Topics: Adult; Ampicillin; beta-Lactams; Clindamycin; Drainage; Ertapenem; Focal Infection, Dental; Gentamicins; Humans; Infections; Klebsiella Infections; Male; Middle Aged; Neck; Periodontal Abscess; Streptococcal Infections; Sulbactam | 2017 |
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline | 2017 |
Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Burns; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genes, MDR; Gentamicins; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pumps; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Should the Aminoglycoside β-Lactam Combination Be Abandoned in All Severely Ill Patients With Presumed Gram-Negative Infection?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Gentamicins; Humans; Prospective Studies; Shock, Septic | 2018 |
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Farmers; Female; Gentamicins; Humans; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Swine; Swine Diseases; Taiwan; Tigecycline; Virginiamycin | 2018 |
Case study on the soil antibiotic resistome in an urban community garden.
Topics: Ampicillin; Anti-Bacterial Agents; Antiporters; Bacterial Proteins; beta-Lactams; Cefoxitin; Ceftriaxone; Chloramphenicol; Cities; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gardens; Gene Expression; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Metagenome; Microbial Sensitivity Tests; Penicillins; Quinolones; Soil Microbiology | 2018 |
Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Gentamicins; Hospitalization; Humans; Male; Organ Dysfunction Scores; Retrospective Studies; Sepsis | 2020 |
Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillins; Retrospective Studies | 2022 |
Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Diosgenin; Escherichia coli; Ethidium; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Saponins; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Genotypic characterization of vancomycin-resistant
Topics: Anti-Bacterial Agents; beta-Lactams; Cross-Sectional Studies; Erythromycin; Fluoroquinolones; Genotype; Gentamicins; Humans; Linezolid; Pristinamycin; Teicoplanin; Tigecycline; Urinary Tract Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Molecular evidence of β-lactam resistant Staphylococcus aureus in equids with respiratory tract infections: Frequency and resistance modulation strategy.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |